Drug Development

Five things for pharma marketers to know: Friday, April 22, 2016

Five things for pharma marketers to know: Friday, April 22, 2016

By

AstraZeneca to sequence two million genomes; Valeant considering Perrigo CEO as its new chief executive; AMA and PhRMA each spent $6 million on lobbying

Top 25 orphan drugs, by 2015 global sales

Top 25 orphan drugs, by 2015 global sales

Roche's Rituxan generated $7.3 billion in sales in 2015, making it the top-selling orphan drug.

OPINION

Email Newsletters